PRICE T ROWE ASSOCIATES INC /MD/
Position in CLDX — Celldex Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$174,337,147
+$108,158,697 QoQ
Shares Held
4,685,223
+124.6% QoQ
Ownership
5.97%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4
of 252 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. CLDX ranks #28 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in CLDX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $174,337,147 | 4,685,223 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $174,373,018 | 4,686,187 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $66,178,450 | 2,086,332 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $55,398,387 | 2,039,705 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $61,635,740 | 2,382,518 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $77,692,636 | 3,817,820 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $61,900,556 | 3,410,499 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $89,888,826 | 3,557,136 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $97,903,605 | 2,880,365 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $117,410,486 | 3,172,399 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $129,570,119 | 3,087,208 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,748,139 | 422,293 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $12,880,872 | 468,055 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,238,015 | 478,574 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $25,673,960 | 713,562 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $37,127,210 | 833,009 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,970,284 | 746,008 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,380,517 | 533,402 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $35,910,309 | 1,054,325 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $35,379,093 | 915,608 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $47,425,301 | 878,409 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,009,765 | 389,048 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,843,938 | 332,230 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,134,551 | 293,068 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||